Mitral valve abnormalities in congestive heart failure: An interplay between form and function?

Journal of the American College of Cardiology

Volumn 45, Issue 1, 2005, Pages 62-64

  O'Brien, Kevin D ^a,b   Fishbein, Daniel P ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ALPHA 1 ADRENERGIC RECEPTOR; ANGIOTENSIN; BETA ADRENERGIC RECEPTOR; COLLAGEN; DNA; GLYCOSAMINOGLYCAN; LOSARTAN; MYOSIN; NEUROHORMONE; TRANSFORMING GROWTH FACTOR BETA1;

APOPTOSIS; CELL TYPE; CONGESTIVE HEART FAILURE; ECHOCARDIOGRAPHY; EXPLANT; EXTRACELLULAR MATRIX; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART TRANSPLANTATION; HEMODYNAMIC MONITORING; HUMAN; MITRAL VALVE DISEASE; MITRAL VALVE REGURGITATION; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 11144243483     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.10.013     Document Type: Editorial

References (31)

1. J.B. Patel, D.D. Borgeson, M.E. Barnes, C.S. Rihal, R.C. Daly, M.M. Redfield Mitral regurgitation in patients with advanced systolic heart failure J Card Fail 10 2004 285 291
2. L.W. Stevenson, D. Bellil, M. Grover-McKay Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am J Cardiol 60 1987 654 658
3. M.A. Hamilton, L.W. Stevenson, J.S. Child, J.D. Moriguchi, J. Walden, M. Woo Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathy Am J Cardiol 67 1991 259 263
4. S.F. Bolling, G.M. Deeb, L.A. Brunsting, D.S. Bach Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy J Thorac Cardiovasc Surg 109 1995 676 682
5. D.M. Kaye, M. Byrne, C. Alferness, J. Power Feasibility and short-term efficacy of percutaneous mitral annular reduction for the therapy of heart failure-induced mitral regurgitation Circulation 108 2003 1795 1797
6. M.R. Mehra, M. Gheorghiade, R.O. Bonow Mitral regurgitation in chronic heart failure: more questions than answers? Curr Cardiol Rep 6 2004 96 99
7. S. Ghio, C. Constantin, C. Klersy Interventricular and intraventricular dyssynchrony are common in heart failure patients, regardless of QRS duration Eur Heart J 25 2004 571 578
8. W.T. Abraham, W.G. Fisher, A.L. Smith Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853
9. M.R. Bristow, L.A. Saxon, J. Boehmer Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure N Engl J Med 350 2004 2140 2150
10. M.G. John Sutton, T. Plappert, W.T. Abraham Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure Circulation 107 2003 1985 1990
11. K.J. Grande-Allen, A.G. Borowski, R.W. Troughton Apparently normal mitral valves in heart failure patients demonstrate biochemical and structural derangements: an extracellular matrix and echocardiographic study J Am Coll Cardiol 45 2005 54 61
12. D.W. Quick, K.S. Kunzelman, J.M. Kneebone, R.P. Cochran Collagen synthesis is upregulated in mitral valves subjected to altered stress ASAIO J 43 1997 181 186
13. K.S. Kunzelman, D.W. Quick, R.P. Cochran Altered collagen concentration in mitral valve leaflets: biochemical and finite element analysis Ann Thorac Surg 66 1998 S198 205
14. G.S. Francis, J.N. Cohn, G. Johnson, T.S. Rector, S. Goldman, A. Simon Plasma norepinephrine, plasma renin activity, and congestive heart failure Relations to survival and the effects of therapy in V-HeFT II. The V-HeFT VA Cooperative Studies Group Circulation 87 1993 VI40 8
15. M.G. Kinsella, S.L. Bressler, T.N. Wight The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype Crit Rev Eukaryot Gene Expr 14 2004 203 234
16. J.D. Bisognano, H.D. Weinberger, T.J. Bohlmeyer Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice J Mol Cell Cardiol 32 2000 817 830
17. B.D. Lowes, E.M. Gilbert, W.T. Abraham Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents N Engl J Med 346 2002 1357 1365
18. T.J. Kemp, I.K. Aggeli, P.H. Sugden, A. Clerk Phenylephrine and endothelin-1 upregulate connective tissue growth factor in neonatal rat cardiac myocytes J Mol Cell Cardiol 37 2004 603 606
19. A. Leask, A. Holmes, D.J. Abraham Connective tissue growth factor: a new and important player in the pathogenesis of fibrosis Curr Rheumatol Rep 4 2002 136 142
20. C.G. Brilla, G. Zhou, L. Matsubara, K.T. Weber Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone J Mol Cell Cardiol 26 1994 809 820
21. B. Pitt, F. Zannad, W.J. Remme The effect of spironolactone on morbidity and mortality in patients with severe heart failure Randomized Aldactone Evaluation Study Investigators N Engl J Med 341 1999 709 717
22. B. Pitt, W. Remme, F. Zannad Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 2003 1309 1321
23. A.A. Lee, W.H. Dillmann, A.D. McCulloch, F.J. Villarreal Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts J Mol Cell Cardiol 27 1995 2347 2357
24. B. Levine, J. Kalman, L. Mayer, H.M. Fillit, M. Packer Elevated circulating levels of tumor necrosis factor in severe chronic heart failure N Engl J Med 323 1990 236 241
25. D. Gurantz, R.T. Cowling, F.J. Villarreal, B.H. Greenberg Tumor necrosis factor-alpha upregulates angiotensin II type 1 receptors on cardiac fibroblasts Circ Res 85 1999 272 279
26. E. Schonherr, P. Witschprehm, B. Harrach, H. Robenek, J. Rauterberg, H. Kresse Interaction of biglycan with type-I collagen J Biol Chem 270 1995 2776 2783
27. R. Riessen, J.M. Isner, E. Blessing, C. Loushin, S. Nikol, T.N. Wight Regional differences in the distribution of the proteoglycans biglycan and decorin in the extracellular matrix of atherosclerotic and restenotic human coronary arteries Am J Pathol 144 1994 962 974
28. K.D. O'Brien, K.L. Olin, C.E. Alpers Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins Circulation 98 1998 519 527
29. K. Tiede, K. Stoter, C. Petrik Angiotensin II AT(1)-receptor induces biglycan in neonatal cardiac fibroblasts via autocrine release of TGF-beta in vitro Cardiovasc Res 60 2003 538 546
30. M.S. Ahmed, E. Oie, L.E. Vinge Induction of myocardial biglycan in heart failure in rats--an extracellular matrix component targeted by AT(1) receptor antagonism Cardiovasc Res 60 2003 557 568
31. K.D. O'Brien, D.M. Shavelle, M.T. Caulfield Association of angiotensin-converting enzyme with low-density lipoprotein in aortic valvular lesions and in human plasma Circulation 106 2002 2224 2230